Platelet activity and hypercoagulation in type 2 diabetes.
Lesha PretoriusGreig J A ThomsonRozanne C M AdamsTheo A NellWillem A LaubscherDouglas B KellPublished in: Cardiovascular diabetology (2018)
Cumulatively, this provides mechanistic evidence that pathological states of platelets together with amyloid fibrin(ogen) in T2DM, might underpin an increased risk for cardiovascular events.